Superior Reports Full Year and Fourth Quarter 2024 Financial Results. Achieved critical milestones in Company transformation.

In its fiscal Q4 2025, which ended Jan. 31, financial performance was robust. Total revenue rose 20% year over year to $548.4 ...

VOQUEZNA® (vonoprazan) generated $55.3 million in 2024 net revenues in its first full year of launch, driven by strong demand, including $29.7 ...

Limited ('Dingdong' or the 'Company') (NYSE: DDL), a leading fresh grocery e-commerce company in China, with advanced supply chain capabilities, today announced its unaudited financial results for the ...